Catherine Mitchell

13PUBLICATIONS

84CO-AUTHORS

Predictive and prognostic markersMolecular targetsRadiation therapyParamedicineSolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 19, 2026

Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.

|Mar 16, 2026

Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies.

Ciara Conduit, Bruno Valentin Sinn, Catherine Mitchell

|Dec 24, 2025

Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative Radiotherapy.

Adel Shahnam, Nicholas Hardcastle, David E Gyorki

|Nov 11, 2025

Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory.

Adel Shahnam, Catherine Mitchell, Christopher R McEvoy

|Oct 29, 2025

Survival Outcomes and Prognostic Factors in Metastatic Unresectable Appendiceal Adenocarcinoma Treated with Palliative Systemic Chemotherapy: A 10-Year Retrospective Analysis from Australia.

Jirapat Wonglhow, Hui-Li Wong, Michael Michael

|Jul 11, 2025

Paraganglioma: An Important Differential for Retroperitoneal Masses.

Timothy Kenyon-Smith, Kelly Ruecker, Gregory Turner

Pageof 3

Frequent Collaborators

Alexander Heriot

Joseph H A Vissers

Eyal Mor

King Tung Cheung

Enoch Wong

Javier Octavio Mejía-Hernández

Nicholas Clemons

Kenji Fujihara

David Byrne

Shahneen Sandhu

Frequent Collaborators

Alexander Heriot

Joseph H A Vissers

Eyal Mor

King Tung Cheung